Valuation: Kuros Biosciences AG

Market Cap 739M 891M 792M 674M 1.27B 85.68B 1.28B 8.94B 3.47B 43.8B 3.35B 3.27B 141B P/E 2026 *
90.3x
P/E 2027 * 42.9x
Enterprise Value 728M 878M 780M 664M 1.25B 84.44B 1.26B 8.82B 3.42B 43.17B 3.3B 3.23B 139B EV / Sales 2026 *
4.37x
EV / Sales 2027 * 3.32x
Free-Float
65.62%
Yield 2026 *
-
Yield 2027 * -
1 day-1.17%
1 week+5.79%
Current month+1.86%
1 month+3.10%
3 months-2.56%
6 months-18.79%
Current year-32.21%
1 week 17.07
Extreme 17.07
19.62
1 month 16.46
Extreme 16.46
19.62
Current year 16.46
Extreme 16.46
30.3
1 year 16.46
Extreme 16.46
34.2
3 years 2.02
Extreme 2.02
34.2
5 years 1.11
Extreme 1.11
34.2
10 years 1.11
Extreme 1.11
34.2
Manager TitleAgeSince
Chief Executive Officer 56 2023-10-11
Chief Executive Officer 60 2017-12-03
Director of Finance/CFO - 2023-02-16
Director TitleAgeSince
Chairman 69 2018-06-13
Director/Board Member 60 2018-06-13
Director/Board Member 57 2018-06-13
Date Insider Type Main position Quantity % Market Cap. Importance
5/26/26 Sell -7,225 0.0184%
12/13/25 Sell 30,000 0.0766%
12/8/25 Sell 30,000 0.0766%
Change 5-day change 1-year change 3-year change Capi.($)
-1.17%+5.79%-34.63%+791.39% 891M
+4.16%+3.04%+49.37%+94.17% 74.16B
-3.11%-3.53%+20.19%+81.44% 57.39B
+0.89%-0.63%+2.17%+36.19% 47.64B
+0.36%+0.81%+342.39%+742.40% 44.29B
-0.96%-4.50%+24.96%+35.38% 42.5B
-0.20%-0.77%+4.13%+105.50% 40.71B
-0.54%+2.93%+9.31%+50.41% 30.97B
-2.68%+2.92%+29.33%+22.72% 28.53B
+0.05%-1.64%-8.14%-11.37% 24.34B
Average -0.32%+0.05%+43.91%+194.82% 39.14B
Weighted average by Cap. +0.12%-0.82%+56.75%+139.75%

Financials

2026 *2027 *
Net sales 167M 201M 179M 152M 286M 19.32B 289M 2.02B 781M 9.87B 754M 738M 31.69B 216M 260M 231M 197M 371M 25.02B 375M 2.61B 1.01B 12.79B 977M 956M 41.06B
Net income 9.32M 11.24M 9.99M 8.5M 16.02M 1.08B 16.17M 113M 43.71M 552M 42.2M 41.29M 1.77B 19.23M 23.19M 20.61M 17.53M 33.06M 2.23B 33.37M 233M 90.2M 1.14B 87.08M 85.19M 3.66B
Net Debt -10.7M -12.9M -11.46M -9.75M -18.39M -1.24B -18.56M -129M -50.16M -634M -48.43M -47.37M -2.03B -23.34M -28.15M -25.01M -21.27M -40.12M -2.71B -40.5M -282M -109M -1.38B -106M -103M -4.44B
Logo Kuros Biosciences AG
Kuros Biosciences AG is a Switzerland‑based biotechnology company engaged in the research, development, and commercialization of biologic technologies for musculoskeletal care, with a focus on those supporting bone regeneration and bone growth. The Company's key product is MagnetOs, which is a synthetic bone graft technology available in multiple formats such as granules or putty. MagnetOs is designed to stimulate bone formation, including through mechanisms that engage the body’s immune response. The technology behind MagnetOs is associated with osteoimmunology, which involves immune‑modulated bone healing. MagnetOs uses the proprietary NeedleGrip submicron surface technology, which supports bone growth by enhancing biological responses related to healing. It is indicated for use across the skeletal system and is positioned as a bone graft option for procedures involving various anatomical regions.
Employees
213
Date Price Change Volume
26-10-02 CHF 18.63 -1.17% 250,793
26-10-01 CHF 18.85 +3.06% 371,222
26-09-30 CHF 18.29 +2.01% 221,517
26-09-29 CHF 17.93 +3.94% 141,976
26-09-28 CHF 17.25 -2.04% 158,401
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
18.63CHF
Average target price
34.29CHF
Spread / Average Target
+84.04%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KURN Stock